Cargando…
Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
BACKGROUND AND OBJECTIVE: Atrial fibrillation (AF), the most common cardiac arrhythmia, typically increases with age. Oral anticoagulants (OACs) are the cornerstone of treatment to reduce the associated risk for systemic thromboembolism. Four large randomized controlled trials (RCTs) have shown that...
Autores principales: | Grymonprez, Maxim, Steurbaut, Stephane, De Backer, Tine L., Petrovic, Mirko, Lahousse, Lies |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509201/ https://www.ncbi.nlm.nih.gov/pubmed/33013422 http://dx.doi.org/10.3389/fphar.2020.583311 |
Ejemplares similares
-
Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants: A nationwide cohort study
por: Grymonprez, Maxim, et al.
Publicado: (2023) -
Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study
por: Grymonprez, Maxim, et al.
Publicado: (2023) -
Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort study
por: Grymonprez, Maxim, et al.
Publicado: (2023) -
Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study
por: Grymonprez, Maxim, et al.
Publicado: (2022) -
The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta‐analysis on the obesity paradox
por: Grymonprez, Maxim, et al.
Publicado: (2021)